AUSTRALIA'S medicines regulator, the Therapeutic Goods Administration (TGA), is warning consumers looking to boost their tan to avoid Melanotan products.
In a statement issued on Fri, the TGA noted that Melanotan-I and Melanotan-II were not approved for marketing in Australia, stressing the products were not melatonin.
The TGA said young people were particularly vulnerable to the marketing of the "imagine-enhancing" products, "as they seek 'miracle' solutions to body and performance pressures".
The regulator reported that the Melanotan products were associated with side-effects including darkened skin, increased moles and freckles, nausea, vomiting, involuntary stretching and yawning, and spontaneous erections.
The TGA also warned advertisers, including social media influencers, that it will take action against businesses and people who breach the Therapeutic Goods Act 1989, with fines of up to $888,000 for individuals and $4.44 million for corporations.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Oct 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Oct 22
